European undergraduate education in oncology. A report of the EORTC Education Branch.

Undergraduate cancer education in Spain: The debate, the opportunities and the initiatives of the University Forum of the Spanish Society of Radiation Oncology (SEOR). Rep Pract Oncol Radiother (2013) 0.75

Developing Canadian oncology education goals and objectives for medical students: a national modified Delphi study. CMAJ Open (2016) 0.75

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet (1992) 5.59

Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med (2001) 3.98

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood (2000) 3.13

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol (1989) 2.43

French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy. Crit Care Med (2001) 2.39

Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol (1994) 2.02

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol (2001) 2.01

Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Qual Life Res (1996) 1.95

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON. Lancet (1992) 1.92

Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood (1998) 1.90

Alteration in crossbridge kinetics caused by mutations in actin. Nature (1990) 1.87

Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer (1967) 1.65

Visualizing single molecules inside living cells using total internal reflection fluorescence microscopy. Methods (2003) 1.64

Filling the lacuna between research and practice: an interview with Michael Peckham. Interview by Richard Smith. BMJ (1993) 1.57

Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood (1991) 1.52

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood (2001) 1.48

Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol (1998) 1.44

Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol (1989) 1.40

[Priority surveys: include the ethical principles in the health care law. Interview by Jan Lind]. Lakartidningen (1995) 1.39

In vitro sensitivity of normal and leukemic myeloid clonogenic cells to hyperthermia: absence of selective effect. Exp Hematol (1989) 1.38

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. J Clin Oncol (1998) 1.32

Labile heat and changes in rate of relaxation of frog muscles. J Physiol (1986) 1.30

Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood (1991) 1.29

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893). Leukemia (1997) 1.28

Compliance with triage to intensive care recommendations. Crit Care Med (2001) 1.28

Overexpression of cyclin D2 in chronic B-cell malignancies. Blood (1995) 1.26

Health care: what's science got to do with it? BMJ (1995) 1.23

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia (2003) 1.21

Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood (1998) 1.21

A Swedish cancer-environment register available for research. Scand J Work Environ Health (1981) 1.19

Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med (1998) 1.17

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience. Haemophilia (1998) 1.16

The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood (2000) 1.12

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia (1997) 1.10

Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus (1990) 1.09

Microtubule assembly in cultured myoblasts and myotubes following nocodazole induced microtubule depolymerisation. J Muscle Res Cell Motil (2003) 1.08

Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung (1992) 1.08

Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children. AIDS (1999) 1.06

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer (1999) 1.06

[Chromosome analyses in idiopathic acquired sideroblastic anemia. A study of 6 cases]. Nouv Rev Fr Hematol (1967) 1.06

Different regional effects of voluntary exercise on the mechanical and electrical properties of rat ventricular myocytes. J Physiol (2002) 1.05

Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology (1996) 1.05

Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood (1998) 1.04

Protein engineering and the study of muscle contraction in Drosophila flight muscles. J Cell Sci Suppl (1991) 1.04

Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int J Cancer (1996) 1.02

Antitumor activity of sodium valproate in cultures of human neuroblastoma cells. Anticancer Drugs (1996) 1.02

Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood (1999) 1.01

Alignment of myoblasts on ultrafine gratings inhibits fusion in vitro. Int J Biochem Cell Biol (2002) 0.99

Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group. Blood (1997) 0.99

Preferential adhesion to and survival on patterned laminin organizes myogenesis in vitro. Exp Cell Res (1997) 0.99

Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anticancer Drugs (1997) 0.98

Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res (1998) 0.97

Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression. Leukemia (1993) 0.96

Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients. J Clin Microbiol (1989) 0.95

A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol (1996) 0.94

Annotation: Subacute and chronic myelomonocytic leukaemia: a distinct haematological entity. Br J Haematol (1976) 0.94

Fournier's gangrene during induction treatment of acute promyelocytic leukemia, a case report. Ann Hematol (1998) 0.94

Thyroid antibodies after 131-I treatment for hyperthyroidism. J Clin Endocrinol Metab (1965) 0.93

Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol (1999) 0.93

Replication of human cytomegalovirus in a rhabdomyosarcoma cell line depends on the state of differentiation of the cells. Arch Virol (1994) 0.92

wt1 gene expression in childhood leukemias. Acta Haematol (1999) 0.92

Hypothyroidism after external irradiation to the thyroid region. Radiology (1967) 0.91

Myogenic cells express multiple myosin isoforms. J Muscle Res Cell Motil (1997) 0.91

"Bad risk" non-Hodgkin lymphomas. Semin Hematol (1983) 0.91

MDR1/P-glycoprotein in haematological neoplasms. Eur J Cancer (1996) 0.91

Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol (1999) 0.90

Conventional and superfractionated radiation therapy in Burkitt's lymphoma. Acta Radiol Ther Phys Biol (1971) 0.90

Evidence for differential post-translational modifications of slow myosin heavy chain during murine skeletal muscle development. J Muscle Res Cell Motil (2000) 0.90

The sarcomere length dependence of the rate of heat production during isometric tetanic contraction of frog muscles. J Physiol (1984) 0.89

Waldenström's macroglobulinaemia in a bird breeder: a case history with pulmonary involvement and antibody activity of the monoclonal IgM to canary's droppings. Clin Exp Immunol (1987) 0.89

The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921). Leukemia (2003) 0.89

Letter: HL-A and pernicious anemia. N Engl J Med (1975) 0.89

Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis. Int J Oncol (1999) 0.89

Expression of human leukocyte antigens class I and class II on cultured biliary epithelial cells after cytomegalovirus infection. Tissue Antigens (1997) 0.88

Functional results after partial pelvic resection in Ewing's sarcoma of the ilium. Arch Orthop Trauma Surg (1999) 0.88

Thyroid antibodies in euthyroid subjects after iodine-131 therapy. Radiat Res (1966) 0.88

Effect of folate and cobalamin compounds on the deoxyuridine suppression test in vitamin B12 and folate deficiency. Blood (1978) 0.88

Homoharringtonine: an effective new natural product in cancer chemotherapy. Bull Cancer (1995) 0.88

Clinical futures. Are as important to health policy as economic and social futures. BMJ (1998) 0.88

Spontaneous remission in adult acute leukemia. Cancer (1985) 0.88

[Waldenstrôm's macroglobulinemia. Developmental and prognostic study]. Sem Hop (1975) 0.88

N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. Bone Marrow Transplant (1993) 0.87

Prediction of the response to chemotherapy in acute leukemia. Cancer (1975) 0.87

Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses. Cell Biol Int (1993) 0.87

Epidemiology of inhibitors in haemophilia A. Vox Sang (1996) 0.87

Disseminated superficial porokeratosis after autologous bone marrow transplantation. Bone Marrow Transplant (1997) 0.87

Imaging myosin 10 in cells. Biochem Soc Trans (2004) 0.87

Evaluation of glycosylation and malonylation patterns in flavonoid glycosides during LC/MS/MS metabolite profiling. J Mass Spectrom (2008) 0.87

Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia. Leukemia (1987) 0.86

Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis. Ann Hematol (1998) 0.85

Normal human bone marrow cultures in vitro: cellular composition and maturation of the granulocytic colonies. Br J Haematol (1977) 0.85

[Pseudolymphoma and lymphoproliferative syndromes in Gougerot-Sjögren syndrome (author's transl)]. Sem Hop (1979) 0.85

Splenic marginal zone lymphoma with or without plasmacytic differentiation. Am J Surg Pathol (2000) 0.85

A modular questionnaire for the assessment of longterm quality of life in leukaemia patients: the MRC/EORTC QLQ-LEU. Qual Life Res (1996) 0.85

Pregnancy during myelosuppressive treatment for chronic myelogenous leukemia. Br J Haematol (1992) 0.85

[Subacute myelo-monocytic leukemia. Study of 27 cases and review of the literature]. Sem Hop (1972) 0.85

Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br J Haematol (1996) 0.85

Sphenoid sinus localization of multiple myeloma revealing evolution from benign gammopathy. Head Neck (1997) 0.84

Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. Br J Haematol (1994) 0.84

Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia (1992) 0.84